| Product Code: ETC13230726 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Angina Market was valued at USD 12.4 Billion in 2024 and is expected to reach USD 20.1 Billion by 2031, growing at a compound annual growth rate of 9.50% during the forecast period (2025-2031).
The global angina market is characterized by a growing prevalence of coronary artery disease (CAD) and an increasing awareness about the condition, leading to a rising demand for angina treatment options. Key players in the market are focusing on developing innovative therapies and medications to address the symptoms and underlying causes of angina, including nitroglycerin, beta-blockers, calcium channel blockers, and statins. Additionally, advancements in diagnostic techniques, such as stress testing and coronary angiography, are aiding in the early detection and management of angina. The market is also witnessing a shift towards non-invasive treatment approaches like lifestyle modifications and cardiac rehabilitation programs. With a significant emphasis on research and development activities, the global angina market is expected to continue expanding, driven by a growing patient population and improving healthcare infrastructure worldwide.
The Global Angina Market is experiencing a shift towards more personalized and targeted treatments, with a focus on innovative therapies and technologies. There is a growing emphasis on non-invasive diagnostic tools and procedures, such as CT angiography and stress echocardiography, to improve early detection and management of angina. Additionally, the rise of telemedicine and digital health solutions presents opportunities for remote monitoring and patient education, enhancing overall care delivery. The market is also witnessing increased investment in research and development of novel drugs and therapies, including gene therapy and stem cell treatments, to address the underlying causes of angina and improve patient outcomes. Overall, the Global Angina Market is evolving to provide more effective and patient-centric solutions for the management of this prevalent cardiovascular condition.
The Global Angina Market faces several challenges, including the rising prevalence of lifestyle-related risk factors such as obesity and smoking, which contribute to the increasing incidence of angina. Additionally, the high cost of treatment options and lack of access to healthcare services in some regions pose barriers to effective management of angina. Furthermore, the development of innovative therapies and diagnostic tools is hampered by regulatory hurdles and stringent approval processes. Patient adherence to treatment plans and lifestyle modifications also present challenges in achieving optimal outcomes in angina management. Overall, addressing these challenges requires collaboration between healthcare providers, pharmaceutical companies, regulatory bodies, and other stakeholders to improve access to care, affordability of treatments, and patient education and compliance.
The Global Angina Market is primarily driven by the increasing prevalence of cardiovascular diseases, rising geriatric population, and unhealthy lifestyle choices leading to risk factors such as obesity and high cholesterol levels. Technological advancements in diagnostic procedures and treatment options, growing awareness about heart health, and government initiatives promoting preventive healthcare measures also contribute to the market growth. Additionally, the rising healthcare expenditure, improved access to healthcare facilities in developing countries, and the introduction of novel therapies and drugs further propel the market expansion. Market players focusing on research and development activities to develop innovative treatment solutions and personalized medicine also play a significant role in driving the Global Angina Market.
Government policies related to the Global Angina Market focus on regulating the approval, pricing, and reimbursement of angina medications and treatments to ensure patient access and safety. Regulatory bodies such as the FDA in the US and the EMA in Europe oversee the approval process for angina drugs, assessing their efficacy and safety before they can be marketed. Pricing policies aim to balance affordability for patients and profitability for manufacturers, with some governments implementing price controls or negotiating discounts with pharmaceutical companies. Reimbursement policies vary by country, with government healthcare systems often covering a portion of the cost of angina treatments to make them more accessible to patients. Overall, government policies play a crucial role in shaping the landscape of the Global Angina Market by balancing innovation, affordability, and patient access.
The Global Angina Market is expected to experience steady growth in the coming years, driven by factors such as the increasing prevalence of cardiovascular diseases, rising geriatric population, and advancements in healthcare technologies. The market is witnessing a shift towards personalized medicine and innovative treatment options, including novel drug therapies and minimally invasive procedures. With a focus on improving patient outcomes and reducing healthcare costs, there is a growing emphasis on preventive measures and early detection of angina. Additionally, emerging markets in Asia-Pacific and Latin America present significant opportunities for market expansion. Overall, the Global Angina Market is poised for sustained growth as healthcare systems worldwide strive to address the burden of cardiovascular diseases effectively.
In the global angina market, Asia is expected to witness significant growth due to the rising prevalence of cardiovascular diseases and improving healthcare infrastructure. North America is a key market for angina treatment, driven by the high incidence of coronary artery disease and the presence of advanced healthcare facilities. In Europe, the market is characterized by a growing geriatric population and increasing awareness about heart health. The Middle East and Africa region is experiencing a rise in cardiovascular disorders, leading to a growing demand for angina treatment options. Latin America is also showing promising growth opportunities in the angina market, driven by improving access to healthcare services and a focus on preventive care initiatives. Overall, these regional insights highlight the diverse factors influencing the global angina market landscape.
Global Angina Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Angina Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Angina Market Revenues & Volume, 2021 & 2031F |
3.3 Global Angina Market - Industry Life Cycle |
3.4 Global Angina Market - Porter's Five Forces |
3.5 Global Angina Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Angina Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Global Angina Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.8 Global Angina Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Angina Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Angina Market Trends |
6 Global Angina Market, 2021 - 2031 |
6.1 Global Angina Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Angina Market, Revenues & Volume, By Beta Blockers, 2021 - 2031 |
6.1.3 Global Angina Market, Revenues & Volume, By Nitrates and Calcium Channel Blockers, 2021 - 2031 |
6.1.4 Global Angina Market, Revenues & Volume, By Angiotensin-Converting Enzyme Inhibitors, 2021 - 2031 |
6.1.5 Global Angina Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Angina Market, Revenues & Volume, By Types, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Angina Market, Revenues & Volume, By Stable Angina and Unstable Angina, 2021 - 2031 |
6.2.3 Global Angina Market, Revenues & Volume, By Variant (Prinzmetal) Angina, 2021 - 2031 |
6.2.4 Global Angina Market, Revenues & Volume, By Microvascular Angina, 2021 - 2031 |
6.3 Global Angina Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Angina Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Angina Market, Revenues & Volume, By Cardiology Centers, 2021 - 2031 |
6.3.4 Global Angina Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Angina Market, Overview & Analysis |
7.1 North America Angina Market Revenues & Volume, 2021 - 2031 |
7.2 North America Angina Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Angina Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Angina Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Angina Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Angina Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 North America Angina Market, Revenues & Volume, By Types, 2021 - 2031 |
7.5 North America Angina Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Angina Market, Overview & Analysis |
8.1 Latin America (LATAM) Angina Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Angina Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Angina Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Angina Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Angina Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Angina Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Angina Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
8.4 Latin America (LATAM) Angina Market, Revenues & Volume, By Types, 2021 - 2031 |
8.5 Latin America (LATAM) Angina Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Angina Market, Overview & Analysis |
9.1 Asia Angina Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Angina Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Angina Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Angina Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Angina Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Angina Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Angina Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
9.4 Asia Angina Market, Revenues & Volume, By Types, 2021 - 2031 |
9.5 Asia Angina Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Angina Market, Overview & Analysis |
10.1 Africa Angina Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Angina Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Angina Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Angina Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Angina Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Angina Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Angina Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
10.4 Africa Angina Market, Revenues & Volume, By Types, 2021 - 2031 |
10.5 Africa Angina Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Angina Market, Overview & Analysis |
11.1 Europe Angina Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Angina Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Angina Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Angina Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Angina Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Angina Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Angina Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
11.4 Europe Angina Market, Revenues & Volume, By Types, 2021 - 2031 |
11.5 Europe Angina Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Angina Market, Overview & Analysis |
12.1 Middle East Angina Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Angina Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Angina Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Angina Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Angina Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Angina Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
12.4 Middle East Angina Market, Revenues & Volume, By Types, 2021 - 2031 |
12.5 Middle East Angina Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Angina Market Key Performance Indicators |
14 Global Angina Market - Export/Import By Countries Assessment |
15 Global Angina Market - Opportunity Assessment |
15.1 Global Angina Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Angina Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
15.3 Global Angina Market Opportunity Assessment, By Types, 2021 & 2031F |
15.4 Global Angina Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Angina Market - Competitive Landscape |
16.1 Global Angina Market Revenue Share, By Companies, 2024 |
16.2 Global Angina Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |